Acer Medical Inc. Statistics
Acer Medical Inc. (6857) Stock Statistics & Valuation Metrics
Total Valuation
Acer Medical Inc. has a market cap or net worth of TWD 1.36B. The enterprise value is ―.
- Market Cap
- TWD 1.36B
- Enterprise Value
- ―
Share Statistics
Acer Medical Inc. has 15,226,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 15,226,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Acer Medical Inc.’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -19.54%.
- Return on Equity (ROE)
- -0.18
- Return on Assets (ROA)
- -0.14
- Return on Invested Capital (ROIC)
- -19.54%
- Return on Capital Employed (ROCE)
- -0.20
- Revenue Per Employee
- 2.73M
- Profits Per Employee
- -1.35M
- Employee Count
- 22
- Asset Turnover
- 0.29
- Inventory Turnover
- 3.98
Valuation Ratios
The current PE Ratio of Acer Medical Inc. is -57.69. Acer Medical Inc.’s PEG ratio is -2.57.
- PE Ratio
- -57.69
- PS Ratio
- 19.45
- PB Ratio
- 8.81
- Price to FCF
- -54.23
- Price to Operating Cash Flow
- -57.48
- PEG Ratio
- -2.57
Income Statement
In the last 12 months, Acer Medical Inc. had revenue of 60.05M and earned -29.69M in profits. Earnings per share was -1.95.
- Revenue
- 60.05M
- Gross Profit
- 36.60M
- Operating Income
- -32.73M
- Pretax Income
- -29.69M
- Net Income
- -29.69M
- EBITDA
- -31.50M
- Earnings Per Share (EPS)
- -1.95
Cash Flow
In the last 12 months, operating cash flow was -23.88M and capital expenditures -1.39M, giving a free cash flow of -25.27M billion.
- Operating Cash Flow
- -23.88M
- Free Cash Flow
- -25.27M
- Free Cash Flow per Share
- -1.66
Dividends & Yields
Acer Medical Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.86%
- Earnings Yield
- -1.75%
Stock Price Statistics
- Beta
- 0.15
- 52-Week Price Change
- -27.82%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 39.27
- Average Volume (3m)
- 781
Financial Position
Acer Medical Inc. as a current ratio of 4.74, with Debt / Equity ratio of 1.56%
- Current Ratio
- 4.74
- Quick Ratio
- 4.60
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 5.51
- Interest Coverage Ratio
- -2518.00
Taxes
In the past 12 months, Acer Medical Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Acer Medical Inc. EV to EBITDA ratio is -47.59, with an EV/FCF ratio of -47.54.
- EV to Sales
- 17.05
- EV to EBITDA
- -47.59
- EV to Free Cash Flow
- -47.54
- EV to Operating Cash Flow
- -50.30
Balance Sheet
Acer Medical Inc. has TWD 153.77M in cash and marketable securities with TWD 0.00 in debt, giving a net cash position of TWD 153.77M billion.
- Cash & Marketable Securities
- TWD 153.77M
- Total Debt
- TWD 0.00
- Net Cash
- TWD 153.77M
- Net Cash Per Share
- TWD 10.10
- Tangible Book Value Per Share
- TWD 9.88
Margins
Gross margin is 63.75%, with operating margin of -37.75%, and net profit margin of -33.62%.
- Gross Margin
- 63.75%
- Operating Margin
- -37.75%
- Pretax Margin
- -33.62%
- Net Profit Margin
- -33.62%
- EBITDA Margin
- -35.83%
- EBIT Margin
- -37.75%
Analyst Forecast
The average price target for Acer Medical Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 27.89%
- EPS Growth Forecast
- 21.86%
